Congress trades
Molina Healthcare, Inc. (MOH)
About Molina Healthcare, Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Chief executive
- Joseph Michael Zubretsky
- Employees
- 19,000
- Listed since
- Jul 2, 2003
- Market value
- $10.1B
- Price to earnings
- 1213.3
- Earnings per share
- -$0.14
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 21, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 22, 2026 | $1.51 | $1.39 | $10.9B | $10.8B | EPS beatRevenue in line |
| Q1 FY2026reported Apr 22, 2026 | $2.35 | $1.90 | $10.8B | $10.9B | EPS beatRevenue in line |
| Q4 FY2025reported Feb 5, 2026 | -$2.75 | $0.43 | $11.4B | $10.9B | EPS missRevenue beat |
| Q3 FY2025reported Oct 22, 2025 | $1.84 | $3.97 | $11.5B | $11.3B | EPS missRevenue beat |
| Q2 FY2025reported Jul 23, 2025 | $5.48 | $5.62 | $11.4B | $11.0B | EPS missRevenue beat |
| Q1 FY2025reported Apr 23, 2025 | $6.08 | $5.97 | $11.1B | $10.8B | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 23, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Joseph M. ZubretskyPresident and Chief Executive Officer | $1.6M | $16.2M | $541K | $18.3M |
| Mark L. KeimChief Financial Officer | $1.0M | $6.3M | $312K | $7.6M |
| James E. WoysChief Operating Officer | $800K | $4.5M | $56K | $5.4M |
| Jeff D. BarlowChief Legal Officer and Secretary | $685K | $3.5M | $210K | $4.4M |
| Debra J. BaconExecutive Vice President, Medicaid | $675K | $2.2M | $57K | $2.9M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $1.5B | 6,572,156 | +3.2% | 12.81% |
| AQR Capital Management LLC | $806.9M | 3,560,601 | +24.3% | 6.94% |
| Vanguard Portfolio Management LLC | $638.1M | 2,790,243 | -0.0% | 5.44% |
| Capital World Investors | $586.1M | 2,562,913 | -19.9% | 5.00% |
| EXOR Capital LLP | $574.4M | 2,511,490 | +100.0% | 4.90% |
| Vanguard Capital Management LLC | $538.6M | 2,355,261 | +1.9% | 4.59% |
| Victory Capital Management Inc | $453.0M | 1,980,615 | -4.4% | 3.86% |
| FMR LLC | $428.0M | 1,871,290 | -41.6% | 3.65% |
| State Street Corp | $401.5M | 1,755,467 | +1.4% | 3.42% |
| Dimensional Fund Advisors LP | $318.7M | 1,393,338 | -0.1% | 2.72% |
| Goldman Sachs Group Inc | $298.8M | 1,306,563 | +79.7% | 2.55% |
| Wellington Management Group LLP | $289.8M | 1,267,207 | +11.9% | 2.47% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in MOH
20 disclosures of 34 on record · median 25d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +47.7%S&P +20.7% · vs S&P 500 +27.0% | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +30.9%S&P +10.9% · vs S&P 500 +20.0% | Feb 24, 2026 | Mar 9, 2026 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +9.8%S&P +12.5% · vs S&P 500 -2.7% | Feb 5, 2026 | Mar 9, 2026 | 32d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +43.1%S&P +11.6% · vs S&P 500 +31.5% | Feb 17, 2026 | Mar 9, 2026 | 20d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +6.2%S&P +10.3% · vs S&P 500 -4.2% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +37.7%S&P +11.6% · vs S&P 500 +26.1% | Nov 12, 2025 | Dec 15, 2025 | 33d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +37.8%S&P +11.9% · vs S&P 500 +25.9% | Nov 10, 2025 | Dec 8, 2025 | 28d |
| Byron DonaldsSpouse | Stock | Sale | $1,001 - $15,000 | +13.6%S&P +17.5% · vs S&P 500 -3.8% | Sep 4, 2025 | Oct 7, 2025 | 33d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +0.6%S&P +14.9% · vs S&P 500 -14.3% | Sep 29, 2025 | Oct 3, 2025 | 4d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +25.1%S&P +21.4% · vs S&P 500 +3.7% | Aug 5, 2025 | Sep 12, 2025 | 38d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +22.8%S&P +20.8% · vs S&P 500 +1.9% | Aug 4, 2025 | Sep 9, 2025 | 36d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +17.6%S&P +19.7% · vs S&P 500 -2.0% | Jul 25, 2025 | Aug 7, 2025 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -36.6%S&P +23.4% · vs S&P 500 -60.1% | Jul 1, 2025 | Aug 7, 2025 | 37d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -35.6%S&P +29.7% · vs S&P 500 -65.3% | May 28, 2025 | Jun 10, 2025 | 13d |
| Robert Bresnahan | Stock | Purchase | $1,001 - $15,000 | -38.2%S&P +29.1% · vs S&P 500 -67.3% | May 15, 2025 | Jun 9, 2025 | 25d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -36.4%S&P +29.4% · vs S&P 500 -65.7% | May 30, 2025 | Jun 6, 2025 | 7d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -39.3%S&P +37.6% · vs S&P 500 -76.9% | Apr 29, 2025 | May 6, 2025 | 7d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -32.3%S&P +24.3% · vs S&P 500 -56.6% | Feb 19, 2025 | Mar 6, 2025 | 15d |
| Robert BresnahanJoint | Stock | Sale | $1,001 - $15,000 | -34.1%S&P +31.1% · vs S&P 500 -65.2% | Jan 13, 2025 | Feb 13, 2025 | 31d |
| Byron DonaldsFiled late | Stock | Purchase | $1,001 - $15,000 | -26.2%S&P +83.4% · vs S&P 500 -109.6% | May 5, 2021 | Nov 8, 2024 | 1283d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
1 member · estimate, as of Sep 10, 20261 member reports a position (estimated). The largest estimated position is in the $1,001 - $15,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Robert Bresnahan | Republican · House | $1,001 - $15,000 | 0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded MOH?
Ro Khanna, Gilbert Ray Cisneros, Jr., Byron Donalds, Robert Bresnahan disclosed MOH transactions in the filings shown here.
Which members of Congress hold MOH?
1 member of Congress reports a position in MOH in the estimate we hold as of Sep 10, 2026. The largest estimated position belongs to Robert Bresnahan. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are MOH trades disclosed?
Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.